克服瘤排水淋巴结中的抗原呈现受损,有助于免疫治疗
Meghan J O'Melia1, Lutz Menzel2, Pin-Ji Lei2
1E. L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA momelia@mgh.harvard.edu lmunn@mgh.harvard.edu tpadera@mgh.harvard.edu.
Journal for immunotherapy of cancer
|December 30, 2025
概括
乳腺瘤会损害树突细胞抗原的呈现,限制抗癌T细胞的反应. 恢复IL-1β或向遥远的淋巴结提供免疫辅助剂可以克服这些障碍,提高免疫治疗的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药物运输 药物运输 药物运输
背景情况:
- 免疫疗法已经改变了癌症护理,但由于针对抗癌免疫反应的有限步骤,往往会失败.
- 大多数免疫疗法并不针对抗原的处理和呈现,这对于免疫反应的发展至关重要.
- 瘤诱导的细胞因子改变可能会损害抗原呈现,提供潜在的治疗点.
研究的目的:
- 研究乳腺瘤如何影响局部区域抗原呈现.
- 为了确定瘤损害树突细胞抗原呈现的机制.
- 探索用于正常化抗原呈现和增强抗癌免疫力的策略.
主要方法:
- 利用乳腺癌的小鼠模型.
- 采用流细胞计,免疫光,共聚焦成像和单细胞RNA测序.
- 评估瘤对局部区域抗原呈现的影响,并测试了补救策略.
主要成果:
- 乳腺瘤损害了瘤排水淋巴结中的树突细胞抗原呈现,限制了T细胞的反应.
- 淋巴结中的IL-1β水平降低是导致抗原呈现受损的原因.
- 向远处淋巴结或恢复IL-1β的免疫辅助剂的向输送改善了抗癌T细胞的反应和存活率,特别是在与免疫检查点阻塞相结合时.
结论:
- 淋巴结抗原呈现的瘤诱导损伤可以通过向免疫辅助剂或IL-1β恢复来克服.
- 这些策略诱导持久的免疫反应,有可能扩大免疫治疗的疗效.
- 这些发现对改善现有的癌症免疫疗法具有临床意义.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.6K
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:40Cell-mediated Immune Responses
83.3K
Overview
83.3K